Neurology Letters
Keywords = Multiple sclerosis
Proposing Strategies to Increase Pregnancy-Related Awareness Among Multiple Sclerosis Patients in Iran
Volume 3, Issue 1, January 2024, Pages 1-2
Elnaz Asadollahzadeh; Sam Daneshvar
The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine
Volume 3, Issue 1, January 2024, Pages 3-11
Mohammad Balabandian; Mobin Mohammadi; Arashk Mallahzadeh
Mind and Art (ORP-01)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Niknam
A narrative review on the dietary interventions in multiple sclerosis (ORP-03)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nasim Rezaeimanesh
Physical disability assessment: EDSS calculation (ORP-05)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Ebadi
Horizons of MS therapy: during 30 years (ORP-06)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Seyed Massood Nabavi
Women and Multiple Sclerosis (ORP-07)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Behnaz Sedighi
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Vida Niakosari; Sana Hashemi; Ahmad Ali Abin; Maryam Poursadeghfard
Definition and treatment of the multiple sclerosis relapse (ORP-10)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Poursadeghfard
Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Nikoo
Everything we need to know about vaccination in MS (ORP-12)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hossein Mozhdehipanah
Typical MRI lesions of multiple sclerosis in the brain and spinal cord (ORP-13)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Hamed
Advanced imaging for multiple sclerosis (ORP-14)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Elnaz Asadollahzadeh
Brain Stimulation for Cognitive impairment in Multiple Sclerosis (ORP-17)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mehrdad Roozbeh
MS and cognition: review of clinical, neuro-radiological features, and treatment (ORP-18)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mahnaz Talebi
Comorbidity in patients with MS (ORP-19)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Fereshteh Ashtari
Review of McDonald criteria (ORP-20)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Atefeh Eidi
Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Karim Nikkhah; Mahshid Mahyad; H. Abbasi
Patients monitoring during treatment with Dimethyl fumarate (ORP-23)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ali Yousefi Pour
New Technological Approach to Physical Therapy in Patients with Multiple Sclerosis (ORP-25)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Hassan Azarsa
EEG Patterns in MS-related epilepsy A literature Review (ORP-26)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Reza Najafi
Epidemiological view of national MS registry in Iran (NMSRI) (ORP-27)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sharareh Eskandarieh
Gut-Brain axis and MS: Is this true? (ORP-29)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Morteza Saeidi
Multiple sclerosis and viral hepatitis (ORP-30)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Raika Jamali
Lower urinary tract dysfunction in Multiple Sclerosis, Updates (ORP-31)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Shekoofeh Alaie
)